Increased expression of galectin-1 is associated with human oral squamous cell carcinoma development | Zendy

Zhang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Increased expression of galectin-1 is associated with human oral squamous cell carcinoma development

Author(s) -

Zhang

Publication year - 2009

Publication title -

oncology reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.094

H-Index - 96

eISSN - 1791-2431

pISSN - 1021-335X

DOI - 10.3892/or_00000312

Subject(s) - oncogene , immunohistochemistry , carcinogenesis , molecular medicine , biology , cancer , galectin , downregulation and upregulation , cell , cancer research , cell cycle , pathology , blot , basal cell , microbiology and biotechnology , medicine , immunology , gene , biochemistry , genetics

Galectin-1 (Gal-1) is a newly found immunoregulatory carbohydrate-binding protein in cancer biology. The purpose of this study was to evaluate the effects of Gal-1 on oral squamous cell carcinoma (OSCC) development. Immunohistochemistry, Western blotting and RT-PCR were carried out in 62 primary OSCC, 38 oral leukoplakia (OPL) tissues to detect the Gal-1 expression in both protein and mRNA levels. Ten normal oral mucosa (NOM) tissues were used as control. Gal-1 protein was significantly overexpressed in OSCC cancer cells and OPL prickle cells compared to NOM (P<0.05). In accordance with Gal-1 protein, Gal-1 mRNA was also up-regulated in OSCC tissues and OPL tissues. Furthermore, both the Gal-1 protein and mRNA in OSCC tissues were higher than in OPL tissues (P<0.05). Our data supports the important roles of Gal-1 in OSCC development and suggests that Gal-1 upregulation in the OSCC and OPL tissues might be a predictor of early oral carcinogenesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research